138 related articles for article (PubMed ID: 38036747)
1. Comment on: "Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis".
Chen S; Chen Y
Am J Clin Dermatol; 2023 Sep; 24(5):853-854. PubMed ID: 38036747
[No Abstract] [Full Text] [Related]
2. Include discussions and review of systems regarding inflammatory bowel disease in patients starting isotretinoin therapy: comment on "Isotretinoin therapy and inflammatory bowel disease".
Mostow EN
Arch Dermatol; 2011 Jun; 147(6):729-30. PubMed ID: 21690538
[No Abstract] [Full Text] [Related]
3. Authors' Reply to Chen and Chen: Comment on: "Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis".
Yu CL; Chou PY; Liang CS; Chiang LH; Wang TY; Tu YK; Chi CC
Am J Clin Dermatol; 2023 Sep; 24(5):855-858. PubMed ID: 38036748
[No Abstract] [Full Text] [Related]
4. Isotretinoin and inflammatory bowel disease.
Bergstrom KG
J Drugs Dermatol; 2010 Mar; 9(3):278-80. PubMed ID: 20232592
[No Abstract] [Full Text] [Related]
5. Isotretinoin: possible component cause of inflammatory bowel disease.
Prokop LD
Am J Gastroenterol; 1999 Sep; 94(9):2568. PubMed ID: 10484032
[No Abstract] [Full Text] [Related]
6. Isotretinoin use and the risk of inflammatory bowel disease.
Thakrar BT; Robinson NJ
Am J Gastroenterol; 2011 May; 106(5):1000-2; author reply 1002-3. PubMed ID: 21540903
[No Abstract] [Full Text] [Related]
7. Inflammatory information.
Weinberg JM
Cutis; 2010 May; 85(5):228-9. PubMed ID: 20540410
[No Abstract] [Full Text] [Related]
8. Acne treatment and inflammatory bowel disease: what is the evidence?
Alikhan A; Henderson GP; Becker L; Sciallis GF
J Am Acad Dermatol; 2011 Sep; 65(3):650-654. PubMed ID: 21704420
[No Abstract] [Full Text] [Related]
9. Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.
Stobaugh DJ; Deepak P; Ehrenpreis ED
Eur J Clin Pharmacol; 2013 Apr; 69(4):1041-2. PubMed ID: 23052415
[No Abstract] [Full Text] [Related]
10. Impact of isotretinoin on inflammatory bowel disease flare in patients with preexisting inflammatory bowel disease diagnosis: A cross-sectional study.
Lopez CG; Kwak R; McCormack L; Zhou G; Charrow A
J Am Acad Dermatol; 2022 Dec; 87(6):1399-1400. PubMed ID: 35597387
[No Abstract] [Full Text] [Related]
11. Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris.
Reilly BK; Ritsema TS
JAAPA; 2015 Jul; 28(7):34-9. PubMed ID: 26107793
[TBL] [Abstract][Full Text] [Related]
12. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
Stobaugh DJ; Deepak P; Ehrenpreis ED
J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
[TBL] [Abstract][Full Text] [Related]
13. A causal association between isotretinoin and inflammatory bowel disease has yet to be established.
Crockett SD; Gulati A; Sandler RS; Kappelman MD
Am J Gastroenterol; 2009 Oct; 104(10):2387-93. PubMed ID: 19806085
[TBL] [Abstract][Full Text] [Related]
14. Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.
Yu CL; Chou PY; Liang CS; Chiang LH; Wang TY; Tu YK; Chi CC
Am J Clin Dermatol; 2023 Sep; 24(5):721-730. PubMed ID: 37010780
[TBL] [Abstract][Full Text] [Related]
15. A propensity score matched cohort study identifying an association of acne, but not oral antibiotic or isotretinoin use, with risk of incident inflammatory bowel disease.
Taylor MT; Margolis DJ; Kwatra SG; Barbieri JS
J Am Acad Dermatol; 2023 Apr; 88(4):841-847. PubMed ID: 36682724
[TBL] [Abstract][Full Text] [Related]
16. [30 years with isotretinoin. "Miracle medicine" against acne with many side effects].
Mobacken H; Sundström A; Vahlquist A
Lakartidningen; 2014 Jan 15-28; 111(3-4):93-6. PubMed ID: 24552013
[No Abstract] [Full Text] [Related]
17. Isotretinoin: controversies, facts, and recommendations.
Bauer LB; Ornelas JN; Elston DM; Alikhan A
Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1435-1442. PubMed ID: 27414637
[TBL] [Abstract][Full Text] [Related]
18. Isotretinoin: update on controversial issues.
Prevost N; English JC
J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
[TBL] [Abstract][Full Text] [Related]
19. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.
Crockett SD; Porter CQ; Martin CF; Sandler RS; Kappelman MD
Am J Gastroenterol; 2010 Sep; 105(9):1986-93. PubMed ID: 20354506
[TBL] [Abstract][Full Text] [Related]
20. 69th annual meeting of the American Academy of Dermatology: New Orleans, Louisiana, USA, 4-8 February 2011.
Fraser K
Am J Clin Dermatol; 2011 Jun; 12(3):215-6. PubMed ID: 21469765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
